-
PKM2 Inhibitor (Compound 3k): Evidence & Use
2026-09-22
PKM2 inhibitor (compound 3k) is a selective pyruvate kinase M2 inhibitor with enzyme-level, cellular, and xenograft evidence. The compound shows aerobic glycolysis disruption, antiproliferative activity, and preliminary activity in an ovarian cancer xenograft model, but it remains a preclinical research reagent.
-
Oleic Acid (C18:1(9Z)): Mechanisms and Use
2026-09-22
Oleic Acid, also designated C18:1(9Z), is a monounsaturated fatty acid used to study lipid metabolism, membrane signaling, inflammation, and cancer biology. Its experimental effects depend on cell type, formulation, exposure conditions, and whether it is used alone or in a mixed-fatty-acid model.
-
Sodium Oxamate in LDH-A and Lactate Studies
2026-09-21
Sodium Oxamate is a water-soluble LDH-A probe for separating lactate production, glycolytic flux, and downstream signaling. This workflow-focused guide shows how to use it in cancer metabolism research while avoiding a key interpretation error revealed by a recent microglial white matter injury study.
-
ICG001: Wnt/β-Catenin Pathway Inhibition Workflows
2026-09-21
ICG001 enables selective interrogation of CBP/β-catenin signaling in cancer, fibrosis, and regenerative biology rather than indiscriminate pathway suppression. This guide connects practical dosing and assay controls with the lithium–exosomal Wnt10a osteogenesis study, showing how to test whether β-catenin transcription is required for enhanced bone formation.
-
YAP–TEAD Super-Enhancers in Ectoderm Commitment
2026-09-20
A 2026 Nucleic Acids Research study maps how super-enhancers and three-dimensional chromatin contacts regulate early surface ectoderm commitment from pluripotent stem cells. Its perturbation experiments identify YAP–TEAD activity, particularly TEAD-dependent regulatory control, as an important driver of early enhancer establishment and lineage-associated gene activation.
-
Influenza Hemagglutinin (HA) Peptide: IP Workflow
2026-09-19
Use the Influenza Hemagglutinin (HA) Peptide as a reversible competitor for native elution of HA-tagged proteins and interaction complexes. This workflow connects high-purity epitope chemistry with practical immunoprecipitation, protein purification, and mechanistic studies such as HA-IDH1 validation.
-
Baicalin: From Plasticity to Assay Design
2026-09-18
Baicalin research now spans adult visual plasticity, KEAP1-NRF2/HO-1 pathway modulation, and cancer biology. This article translates the latest mouse findings into practical assay decisions while separating validated mechanisms from promising cross-domain hypotheses.
-
Demethyleneberberine Blocks IL-1β Maturation in UC
2026-09-18
The reference study identifies mitochondrial regulation as a critical link between TLR4 activation and IL-1β maturation in experimental ulcerative colitis. Its evidence positions Demethyleneberberine (DMB) as an anti-inflammatory candidate that preserves mitochondrial homeostasis rather than simply suppressing downstream cytokine release.
-
EZ Cap™ Cy5 EGFP mRNA: Dual-Readout Guide
2026-09-17
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) is a Cy5-labeled mRNA that separates delivery tracking from functional EGFP expression in one reporter construct. Its Cap1 analog, modified uridine chemistry, and dual fluorescence support mRNA delivery and translation efficiency assay workflows, while product-specific handling and assay controls remain essential.
-
Chloramphenicol: From Mechanism to Translational Strategy
2026-09-17
Chloramphenicol is more than a selectable antibiotic: it is a mechanistically defined tool for linking plasmid maintenance, bacterial protein synthesis inhibition, and resistance research. This article connects assay design with recent evidence on carbapenemase-encoding gene dissemination, offering translational researchers a framework for interpreting selection pressure, plasmid mobility, and experimental reproducibility.
-
Zosuquidar: Practical P-gp Resistance Workflows
2026-09-16
Zosuquidar (LY335979) 3HCl provides a focused way to test whether P-glycoprotein efflux is driving chemotherapy or PROTAC resistance. This workflow-oriented guide covers paired-cell assays, sensitization matrices, acquired ABCB1 resistance, and troubleshooting for reproducible translational studies.
-
WNT5a/GSK3/β-Catenin Control of FAP Adipogenesis
2026-09-16
The reference study identifies the WNT5a/GSK3/β-catenin axis as a key regulator of adipogenic drift in skeletal-muscle fibro/adipogenic progenitors. Its integration of pharmacology, mass cytometry, animal models, and transcriptomic network analysis connects pathway activity with fatty degeneration and pro-myogenic support, while also defining important limits for translating the findings to other research areas.
-
Dorsomorphin 2HCl: Reading AMPK Causality
2026-09-15
Dorsomorphin 2HCl is an AMPK inhibitor that helps researchers distinguish pathway association from pathway dependence. This article presents an evidence-centered framework for interpreting metabolic, BMP, osteogenic, and iron-regulation assays without overstating pharmacological causality.
-
Aclacinomycin A and Persistent rDNA Stress
2026-09-15
Aclacinomycin A is more than a cytotoxicity reagent: it can help researchers distinguish acute DNA damage from persistent nucleolar stress and apoptosis. This article translates recent PML-nucleolar compartment research into a rigorous framework for interpreting topoisomerase inhibition, rDNA lesions, and cell-fate readouts.
-
Ceftazidime in Resistance-Aware Bacterial Research
2026-09-14
Ceftazidime is a third-generation cephalosporin with particular value in Gram-negative bacterial infection research. This article explains how its phenotype, handling requirements, and mechanistic boundaries can be integrated with carbapenemase and transmission studies without confusing susceptibility testing with gene detection.